Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - August 2014


Mass Spectrometry Principles and Practice

04 Aug 2014 - 08 Aug 2014 - Stockton, CA, USA



Bookmark and Share


This unique, 5-day lecture and hands-on laboratory course is the most comprehensive training available for the analyst using chromatography / mass spectrometry. Taught by a team of expert instructors, participants will leave with an understanding of key mass spectrometry principles, practical lab experience, and reference materials, enabling them to put their newly-acquired knowledge into use immediately. Instruments from the world’s leading mass spectrometry vendors are used in the course, giving attendees the opportunity to obtain hands-on experience with state-of-the-art instrumentation. The lab experiments are real-life, practical exercises that reinforce the fundamental concepts presented in lecture. Participants work in teams to conduct exercises, interpret experimental data and present their results. The course is a true collaborative learning experience—students are encouraged to ask questions and learn from each other, as well as the instructors. Who Should Attend: Scientists and analysts wishing to quickly deepen their practical LC/MS and GC/MS knowledge and experience Class size is limited to 26 students, so REGISTER NOW to ensure your spot. Partial List of Topics Covered: • Operating basics of LC/MS and GC/MS and ionization techniques • Mass spectral interpretation strategies • Practical advice on operating and maintaining mass spectrometers • Designing and optimizing GC/MS and LC/MS methods and experiments • Using computer tools to analyze LC/MS, GC/MS and MS/MS data Course Location: University of the Pacific, Stockton, California (near San Francisco/Oakland/Sacramento)

Further information
Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!